NCT04380207View on ClinicalTrials.gov

P1 Single and Multiple Ascending Dose (SAD/MAD) Study of IV QPX7728 Alone and Combined With QPX2014 in NHV

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 24, 2020

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions

Bacterial Infections

Interventions

DRUG

QPX7728

antibiotic

DRUG

Placebo

Placebo comparator

DRUG

QPX2014

antibiotic

Trial Locations (2)

90630

Altasciences, Cypress

Unknown

CMAX, Adelaide

All Listed Sponsors

collaborator

Biomedical Advanced Research and Development Authority

FED

lead

Qpex Biopharma, Inc.

INDUSTRY

NCT04380207 - P1 Single and Multiple Ascending Dose (SAD/MAD) Study of IV QPX7728 Alone and Combined With QPX2014 in NHV | Biotech Hunter | Biotech Hunter